Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-08-23 | New | $99,681,169 | $99,681,169 | Equity Only | 06b | SEC link |
| 2022-06-01 | New | $8,000,000 | $8,000,000 | Other | 06b | SEC link |
| 2021-07-20 | New | $9,999,998 | Unknown | Other | SEC link | |
| 2020-07-22 | New | $5,173,587 | $5,173,587 | Other | 06b | SEC link |
| 2020-03-27 | New | $317,167 | $317,167 | Other | 06b | SEC link |
| 2013-11-29 | New | $6,579,122 | $6,579,122 | Equity Only | 06b | SEC link |
| 2013-09-03 | New | $4,600,000 | $4,600,000 | Equity Only | 06 | SEC link |
| 2013-08-07 | New | $52,900 | $52,900 | Equity Only | 06 | SEC link |
| 2013-03-08 | New | $2,100,000 | $2,100,000 | Equity Only | 06 | SEC link |
| 2009-06-22 | New | Yet to Sell | Unknown | Equity Only | 06 | SEC link |
| 2009-06-10 | New | $5,250,000 | Unknown | Equity Only | 06 | SEC link |
| 2008-01-29 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2005-08-08 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| June Almenoff | Director |
| Ronald R. Blanck | Director |
| Steven Boyd | Director |
| William A Chatfield | Director |
| Michael Davidson | Director |
| Anthony Di Tonno | Director, Executive |
| Declan Doogan | Director |
| Melville Engle | Director |
| Christopher T. Giordano | Director, Executive |
| Lawrence R. Hoffman | Executive |
| Robyn M. Hunter | Director |
| Michael Jebsen | Executive |
| John Kelley | Executive |
| Richard Kiral | Director, Executive |
| Gerald Klein | Director |
| Eliot Lurier | Executive |
| Keith Maher | Director |
| James Mitchum | Director |
| Gregory Pepin | Director |
| Gerald T. Proehl | Director |
| Chris A. Rallis | Director |
| Stuart Rich | Director, Executive |
| Charles Seeman | Executive |
| Bruce Spiess | Director |
| Chris Stern | Director, Executive |